These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27187871)

  • 1. Thiolactomycin-Based Inhibitors of Bacterial β-Ketoacyl-ACP Synthases with in Vivo Activity.
    Bommineni GR; Kapilashrami K; Cummings JE; Lu Y; Knudson SE; Gu C; Walker SG; Slayden RA; Tonge PJ
    J Med Chem; 2016 Jun; 59(11):5377-90. PubMed ID: 27187871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel E. coli beta-ketoacyl-acyl carrier protein synthase III inhibitors as targeted antibiotics.
    Lee JY; Jeong KW; Lee JU; Kang DI; Kim Y
    Bioorg Med Chem; 2009 Feb; 17(4):1506-13. PubMed ID: 19185501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slow onset inhibition of bacterial beta-ketoacyl-acyl carrier protein synthases by thiolactomycin.
    Machutta CA; Bommineni GR; Luckner SR; Kapilashrami K; Ruzsicska B; Simmerling C; Kisker C; Tonge PJ
    J Biol Chem; 2010 Feb; 285(9):6161-9. PubMed ID: 20018879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification, characterization, and identification of novel inhibitors of the beta-ketoacyl-acyl carrier protein synthase III (FabH) from Staphylococcus aureus.
    He X; Reynolds KA
    Antimicrob Agents Chemother; 2002 May; 46(5):1310-8. PubMed ID: 11959561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and biological evaluation of a novel series of benzimidazole inhibitors of Francisella tularensis enoyl-ACP reductase (FabI).
    Mehboob S; Song J; Hevener KE; Su PC; Boci T; Brubaker L; Truong L; Mistry T; Deng J; Cook JL; Santarsiero BD; Ghosh AK; Johnson ME
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1292-6. PubMed ID: 25677657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel selective inhibitors of Staphylococcus aureus β-ketoacyl acyl carrier protein synthase III.
    Lee JY; Jeong KW; Shin S; Lee JU; Kim Y
    Eur J Med Chem; 2012 Jan; 47(1):261-9. PubMed ID: 22104972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial beta-ketoacyl-acyl carrier protein synthases as targets for antibacterial agents.
    Khandekar SS; Daines RA; Lonsdale JT
    Curr Protein Pept Sci; 2003 Feb; 4(1):21-9. PubMed ID: 12570782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel inhibitors of the condensing enzymes of the type II fatty acid synthase of pea (Pisum sativum).
    Jones AL; Herbert D; Rutter AJ; Dancer JE; Harwood JL
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):205-9. PubMed ID: 10727420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of thiotetronic acid analogues of thiolactomycin.
    Sakya SM; Suarez-Contreras M; Dirlam JP; O'Connell TN; Hayashi SF; Santoro SL; Kamicker BJ; George DM; Ziegler CB
    Bioorg Med Chem Lett; 2001 Oct; 11(20):2751-4. PubMed ID: 11591516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphenyl-based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme.
    Senior SJ; Illarionov PA; Gurcha SS; Campbell IB; Schaeffer ML; Minnikin DE; Besra GS
    Bioorg Med Chem Lett; 2003 Nov; 13(21):3685-8. PubMed ID: 14552758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of beta-ketoacyl-acyl carrier protein synthases by thiolactomycin and cerulenin. Structure and mechanism.
    Price AC; Choi KH; Heath RJ; Li Z; White SW; Rock CO
    J Biol Chem; 2001 Mar; 276(9):6551-9. PubMed ID: 11050088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiolactomycin-based β-ketoacyl-AcpM synthase A (KasA) inhibitors: fragment-based inhibitor discovery using transient one-dimensional nuclear overhauser effect NMR spectroscopy.
    Kapilashrami K; Bommineni GR; Machutta CA; Kim P; Lai CT; Simmerling C; Picart F; Tonge PJ
    J Biol Chem; 2013 Mar; 288(9):6045-52. PubMed ID: 23306195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the research of β-ketoacyl-ACP synthase III (FabH) inhibitors.
    Zhang HJ; Li ZL; Zhu HL
    Curr Med Chem; 2012; 19(8):1225-37. PubMed ID: 22257054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Characterisation of the Beta-Ketoacyl-Acyl Carrier Protein Synthases, FabF and FabH, of Yersinia pestis.
    Nanson JD; Himiari Z; Swarbrick CM; Forwood JK
    Sci Rep; 2015 Oct; 5():14797. PubMed ID: 26469877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial natural products as beta-ketoacyl-acyl carrier protein synthase III inhibitors.
    Lee JY; Jeong KW; Shin S; Lee JU; Kim Y
    Bioorg Med Chem; 2009 Aug; 17(15):5408-13. PubMed ID: 19595597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and evaluation of second generation MurF inhibitors based on a cyanothiophene scaffold.
    Hrast M; Anderluh M; Knez D; Randall CP; Barreteau H; O'Neill AJ; Blanot D; Gobec S
    Eur J Med Chem; 2014 Feb; 73():83-96. PubMed ID: 24384549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships at the 5-position of thiolactomycin: an intact (5R)-isoprene unit is required for activity against the condensing enzymes from Mycobacterium tuberculosis and Escherichia coli.
    Kim P; Zhang YM; Shenoy G; Nguyen QA; Boshoff HI; Manjunatha UH; Goodwin MB; Lonsdale J; Price AC; Miller DJ; Duncan K; White SW; Rock CO; Barry CE; Dowd CS
    J Med Chem; 2006 Jan; 49(1):159-71. PubMed ID: 16392800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antibacterial activity of cinnamaldehyde acylhydrazone with a 1,4-benzodioxan fragment as a novel class of potent β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitor.
    Song X; Yang Y; Zhao J; Chen Y
    Chem Pharm Bull (Tokyo); 2014; 62(11):1110-8. PubMed ID: 25196128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a potent enoyl-acyl carrier protein reductase (FabI) inhibitor suitable for antistaphylococcal agent.
    Kim YG; Seo JH; Kwak JH; Shin KJ
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4481-6. PubMed ID: 26343826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial FabH Inhibitors with Mode of Action Validated in Haemophilus influenzae by in Vitro Resistance Mutation Mapping.
    McKinney DC; Eyermann CJ; Gu RF; Hu J; Kazmirski SL; Lahiri SD; McKenzie AR; Shapiro AB; Breault G
    ACS Infect Dis; 2016 Jul; 2(7):456-64. PubMed ID: 27626097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.